STAT+: Skylark Bio kicks off new gene therapy trial for deafness

The White House's order attempting to overhaul the vaccine schedule could subject children to more needles and more disease risk, world health leaders say.

“Across every cancer we studied, patients are waiting longer today than they were a decade ago.”

“Our understanding and treatment of postpartum psychiatric illnesses remain profoundly inadequate,” experts write.

Eli Lilly filed six lawsuits against U.S. companies it accuses of illegally selling black-market versions of its experimental obesity drug retatrutide

In this edition of STAT's AI Prognosis: The messy reality of hastily developing and selling AI tools to clinics, and other health AI news.

Definium Therapeutics said that its LSD therapy significantly helped patients with generalized anxiety disorder in the first of two large trials.

German researcher Georg Schett has made a name for himself as a pioneer in autoimmune disease treatment. Now he's co-founding his own company.

Commure wants to automate health care's administrative tasks with AI. An inside look at the messy realities of the startup's ambitious quest.